Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection
Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection
Recruiting · NCT05254782 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-06-09 | NCT05254782 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ontario Institute for Cancer Research | 4 |
| The Princess Margaret Cancer Foundation | 3 |
| University Health Network, Toronto | 417 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Michael Garron Hospital | Toronto | Canada | 3 |
| St. Joseph's Health Centre | Toronto | Canada | 4 |
| University Health Network | Toronto | Canada | 19 |